Dharmais Cancer Hospital: Leading Indonesia’s Charge Against Cancer

One institution stands at the forefront of Indonesia’s fight against cancer— Dharmais Cancer Hospital, now nationally designated as the country’s Cancer Center. With cutting-edge technology, groundbreaking research, and a patient-first approach, Dharmais is not only treating cancer—it’s transforming the future of oncology in Indonesia.

“Innovation is at the heart of our mission,” says Soeko Werdi Nindito Daroekoesoemo, MD, MARS, Director of Dharmais Cancer Hospital.
“We are not just treating cancer; we are transforming the future of oncology in Indonesia.”

Backed by 15–20% of its annual budget focused on cancer research and education, Dharmais is a powerhouse of learning and discovery. From immunotherapy to early detection training programs, their mission is clear: better outcomes through knowledge.

Expanding Reach Across the Nation

To overcome Indonesia’s vast geography, Dharmais is leading efforts through the National Cancer Control Plan (NCCP) 2024–2034, harmonizing national strategies with the Ministry of Health. Through telemedicine, telementoring (like Project ECHO®), and mobile screening units, the hospital ensures life-saving cancer services reach even the most remote islands. International collaborations, including with MD Anderson Cancer Center, further elevate standards in care and research, while genomic studies aim to personalize treatment across populations.
Dharmais plays a central role in the Biomedical and Genome Science Initiative (BGSi), utilizing Next-Generation Sequencing (NGS) to unlock targeted treatments for cancers such as breast, lung, colorectal, and ovarian. With over 3,000 samples collected since June 2023, the hospital is pioneering precision oncology in Southeast Asia.

Microsurgery & Modern Radiation: Precision in Practice

At Dharmais Cancer Hospital, the blend of surgical precision and advanced radiotherapy isn’t just pushing boundaries—it’s redefining the entire landscape of cancer treatment in Indonesia.
Radiotherapy remains one of the pillars of cancer care—and at Dharmais, it’s being delivered with unmatched precision. With an arsenal of advanced equipment, the hospital ensures patients receive tailored treatments that minimize damage to healthy tissue.

Key Technologies at Dharmais:

• 4 Linear Accelerators (Linacs): Capable of intensity-modulated radiation therapy (IMRT) and electron therapy.
• PET-CT & PET: Pinpoint tumor locations and track metabolic activity.
• SPECT & SPECT-CT: Crucial for functional imaging and hybrid diagnostics.
• MRI & CT Scanners: Providing high- definition structural imaging.
• Tomotherapy: Combining CT scanning with precise radiation delivery.
• Hyperthermia Pumps: Enhancing the effectiveness of radiation by raising tumor temperatures.
• Intraoperative Radiation Therapy: Helps to target cancer cells more precisely while sparing surrounding healthy tissue.

These technologies work together to ensure that each treatment plan is not only effective but deeply personalized.
With a commitment to delivering not only life-saving interventions but also restoring dignity and quality of life, Dharmais has emerged as a national leader in microsurgical oncology and precision radiation therapy.